Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Visualising microglial activation in vivo.

Richard B Banati1

  • 1Department of Neuropathology, Departments of Psychiatry, Molecular Neuropsychiatry, Charing Cross Hospital, Imperial College School of Medicine, and MRC Clinical Sciences Centre (PET Neurology), Hammersmith Hospital, London, United Kingdom.

Glia
|October 16, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and characterisation of novel oxytocin analogues for PET imaging.

Communications chemistry·2025
Same author

TSPO contributes to neuropathology and cognitive deficits in Alzheimer's disease.

Journal of neuroinflammation·2025
Same author

Early Locus Coeruleus noradrenergic axon loss drives olfactory dysfunction in Alzheimer's disease.

Nature communications·2025
Same author

Elemental analysis by neutron activation analysis and synchrotron x-ray fluorescence microscopy of ocean plastics ingested by pelagic seabirds.

Journal of hazardous materials·2025
Same author

Microglia and brain macrophages are differentially associated with tumor necrosis in glioblastoma: A link to tumor progression.

Oncology research·2025
Same author

GRT-X Stimulates Dorsal Root Ganglia Axonal Growth in Culture via TSPO and Kv7.2/3 Potassium Channel Activation.

International journal of molecular sciences·2024
Same journal

Blocking CK2α-Bclaf1 Preserves Oligodendrocytes After Neonatal Hypoxic Injury.

Glia·2026
Same journal

Molecular Characteristics and Differentiation Control Mechanisms of Bergmann Glia-Like Progenitors in the Postnatal Mouse Cerebellum.

Glia·2026
Same journal

Alzheimer's Protection by PLCγ2 Compacts Plaques, Redistributes Microglia, and Protects Synapses in App<sup>NL</sup> <sup>-G-F</sup> Mice.

Glia·2026
Same journal

Single-Nucleus Multiomic Analysis Reveals Immune-Metabolic Reprogramming Consistent With Maladaptive Trained Immunity in HIV-Associated Neurocognitive Disorders.

Glia·2026
Same journal

Plasma Membrane Remodeling During Microglial Activation: A Hypothesis Linking Microglial Shape and Lipid Droplet Formation.

Glia·2026
Same journal

Early Developmental Neuronal Activity Impacts Oligodendrocyte Differentiation Through AMPA Receptors.

Glia·2026
See all related articles

Microglia, brain immune cells, become activated during disease, signaling pathology. Imaging activated microglia using (R)-PK11195 and PET offers new insights into central nervous system (CNS) diseases.

Area of Science:

  • Neuroscience
  • Immunology
  • Radiology

Background:

  • Microglia are quiescent immune cells in the healthy central nervous system (CNS).
  • In disease states, microglia activate and act as sensitive indicators of pathological events.
  • Activated microglia exhibit localized involvement, providing diagnostic potential for disease localization.

Purpose of the Study:

  • To investigate the utility of (R)-PK11195, a ligand for the peripheral benzodiazepine binding site (PBBS), for imaging activated microglia in vivo.
  • To correlate in vivo imaging findings with clinical and histological data in neuroinflammatory and neurodegenerative diseases.

Main Methods:

  • Utilized carbon-11 labeled (R)-PK11195 and positron emission tomography (PET) for in vivo imaging.
  • Correlated regional increases in [(11)C](R)-PK11195 signal with clinical observations of functional loss.

Related Experiment Videos

  • Compared PET findings with histological evidence of microglial activation in lesions and projection areas.

    • Main Results:

    • [(11)C](R)-PK11195 PET demonstrated increased signal in patterns correlating with disease progression and functional deficits.
    • Increased tracer binding mirrored microglial activation in lesion penumbras and affected neural pathways.
    • Evidence suggests glial activation may occur in transsynaptic areas and represent adaptation, not just destruction.

    Conclusions:

    • In vivo imaging of activated microglia using [(11)C](R)-PK11195 provides valuable insights into CNS disease pathology and progression.
    • The injured brain exhibits dynamic glial responses, indicating potential roles in adaptation and plasticity.
    • Further advancements are needed for routine clinical application, but in vivo glial imaging holds promise for understanding brain diseases.